Association of serum oxidized lipoprotein(a) concentration with coronary artery disease: Potential role of oxidized lipoprotein(a) in the vasucular wall

Journal of Atherosclerosis and Thrombosis

Volumn 16, Issue 4, 2009, Pages 410-418

  Morishita, Ryuichi ^a   Ishii, Junichi ^b   Kusumi, Yoshiaki ^c   Yamada, Shingo ^d   Komai, Norio ^e   Ohishi, Minoru ^e   Nomura, Masanori ^f   Hishida, Hitoshi ^f   Niihashi, Mari ^c   Mitsumata, Masako ^c  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SHINO TEST CORPORATION   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcification; Coronary artery disease; Hypertension; Lipoprotein(a); Oxidative stress

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ANGIOCARDIOGRAPHY; ARTERY CALCIFICATION; ARTERY WALL; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART INFARCTION; HUMAN; HUMAN TISSUE; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PULSE WAVE; VASCULAR ENDOTHELIUM;

EID: 73249144129     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.No224     Document Type: Article

References (32)

1. McLean JW, Tomlison JE, Kaung WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM: CDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature, 1987; 330:132-137
2. Hajjar KA, Gavish D, Breslow JL, Nachman RL: Lipoprotein(a) modulation of endothelial surface fibrinolysis and its potential role in atherosclerosis. Nature, 1989; 339:303-305
3. Harpel PC, Gordon BR, Parker TS: Plasmin catalyzes binding of lipoprotein(a) to immobilized fibrinogen and fibrin. Proc Natl Acad Sci USA, 1989; 86:3847-3851
4. Harpel PC, Chang VT, Borth W: Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: A potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism. Proc Natl Acad Sci USA, 1992; 89:10193-10197
5. Jürgens G, Taddei-Peters WC, Költringer P, Peter W, Chen Q, Greilberger J, Macomber PF, Butman BT, Stead AG, Ransom JH: Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease. Stroke, 1995; 26:1841-1848
6. Willeit J, Kiechl P, Santer P, Oberhollenzer G, Egger E, Jarosch A, Mair A: Lipoprotein(a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck Study. Stroke, 1995; 26:1582-1587
7. Schaefer EJ, Lamon-Fava S, Jenner JL, McNamara JR, Ordovas JM, Davis CE, Abolafia JM, Lippel K, Levy: Lipoprotein(a) levels and risk of coronary heart disease in men. The Lipid Research Clinics Coronary Primary Prevention Trial. JAMA, 1994; 27:999-1003
8. Budde T, Fechtrup C, Bösenberg E, Vielhauer C, Enbergs A, Schulte H, Assmann G, Breithardt G: Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis. Arterioscler Thromb, 1994; 14:1730-1736
9. Terres W, Tatsis E, Pfalzer B, Beil FU, Beisiegel U, Hamm CW: Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a). Circulation, 1995; 91:948-950
10. Bostom AG, Cupples LA, Jenner JL, Ordovas JM, Seman LJ, Wilson PW, Schaefer EJ, Castelli WP: Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA, 1996; 276:544-548
11. Ren S, Man RY, Angel A, Shen GX: Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-1 in cultured vascular endothelial cells. Atherosclerosis, 1997; 128:1-10
12. Etingin OR, Hajjar DP, Harpel PC, Nachaman RL: Lipoprotein(a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis. J Biol Chem, 1991; 268:2459-2465
13. Galle J, Bengen J, Schollmeyer P, Wanner C: Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a). Role of oxygen-derived radicals. Circulation, 1995; 92:1582-1589
14. Zioncheck TF, Powell LM, Rice GC, Eaton DL, Lawn RM: Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages. J Clin Invest, 1991; 87:767-771
15. Morishita R, Yamada S, Higaki J, Tomita N, Kida I, Aoki M, Moriguchi A, Hayashi S, Sakurabayashi I, Kaneda Y, Ogihara T: Conditioned medium from HepG2 cells transfected with human apolipoprotein (a) gene stimulates growth of human vascular smooth muscle cells: effects of overexpression of human apolipoprotein (a) gene. Hypertension, 1998; 32:215-222
16. Komai N, Morishita R, Yamada S, Oishi M, Iguchi S, Aoki M, Sakaki M, Sakurabayashi I, Higaki J, Ogihara T: Mitogenic activity of oxidized lipoprotein (a) on human vascular smooth muscle cells. Hypertension, 2002; 40:310-314
17. Yamada S, Morishita R, Nakamura S, Ogihara T, Kusumi Y, Sakurai I, Kubo N, Sakurabayashi I: Development of antibody against epitope of lipoprotein (a) modified by oxidation: evaluation of new enzyme-linked immunoassay for oxidized Lp (a). Circulation, 2000; 102:1639-1644
18. Gaubatz JW, Heideman C, Gotto Jr, AM, Morrisett JD, Dahlen GH: Human plasma lipoprotein(a): Structures properties. J Biol Chem, 1983; 258:4582-4589
19. Yamada S, Inoue K, Morishita R, Ogihara T, Kubono K, Kubo N, Abe A, Sakurabayashi I: A new Lp(a) assay that is unaffected by apo(a) size polymorphism. Clin Chim Acta, 1999; 287:29-43
20. Kamboh MI, Ferrell RE, Kottke BA: Expressed hypervariable polymorphism of apolipoprotein(a). Am J Hum Genet, 1991; 49:1063-1074
21. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, Target R, Levy BI: Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension, 1995; 26:485-490
22. Bortolotto LA, Blacher J, Kondo T, Takazawa K, Safar ME: Assessment of vascular aging and atherosclerosis in hypertensive subjects: second derivative of photoplethysmogram versus pulse wave velocity. Am J Hypertens, 2000; 13:165-171
23. Russo C, Olivieri O, Girelli D, Faccini G, Zenari ML, Lombardi S, Corrocher R: Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens, 1998; 16:1267-1271
24. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M: Does superoxide underlie the pathogenesis of hypertension ? Proc Natl Acad Sci USA, 1991; 88:10045-10048
25. Zhao SP, Xu DY: Oxidized lipoprotein(a) increases the expression of platelet-derived growth factor-B in human umbilical vein endothelial cells. Clin Chim Acta, 2000; 296:121-133
26. Zhao SP, Xu DY: Oxidized lipoprotein(a) enhanced the expression of P-selectin in cultured human umbilical vein endothelial cells. Thromb Res, 2000; 100:501-510
27. Beaudeux JL, Cesarini ML, Gardes-Albert M, Maclouf J, Merval R, Esposito B, Peynet J, Tedgui A: Native and gamma radiolysis-oxidized lipoprotein(a) increase the adhesiveness of rabbit aortic endothelium. Atherosclerosis, 1997; 132:29-35
28. Papagrigorakis E, Iliopoulos D, Asimacopoulos PJ, Safi HJ, Weilbaecher DJ, Ghazzaly KG, Nava ML, Gaubatz JW, Morrisett JD: Lipoprotein(a) in plasma, arterial wall, and thrombus from patients with aortic aneurysm. Clin Genet, 1997; 52:262-271
29. Watson KE, Bostrom K, Ravindranath R, Lam T, Norton B, Demer LL: TGF-β1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cell to calcify. J Clin Invest, 1994; 93:2106-2113
30. Saito E, Wachi H, Sato F, Seyama Y: 7-ketocholesterol, major oxysterol, promotes Pi-induced vascular calcification in cultured smooth muscle cells. J Atheroscler Thromb, 2008; 15:130-137
31. Simons DB, Schwartz RS, Edwards WD, Sheedy PF, Breen JF, Rumberger JA: Noninvasive definition of anatomic coronary artery disease by ultrafast computed tomographic scanning: a quantitative pathologic comparison study. J Am Coll Cardiol, 1992; 20:1118-1126
32. Ehara S, Naruko T, Shirai N, Itoh A, Hai E, Sugama Y, Ikura Y, Ohsawa M, Okuyama T, Shirai N, Yamashita H, Itabe H, Haze K, Yoshiyama M, Ueda M: Small coronary calcium deposits and elevated plasma levels of oxidized low density lipoprotein are characteristic of acute myocardial infarction. J Atheroscler Thromb, 2008; 15:75-81